(Rac)-Naxifylline

CAS No. 166181-76-6

(Rac)-Naxifylline( —— )

Catalog No. M34664 CAS No. 166181-76-6

(Rac)-Naxifylline may be used to study congestive heart failure.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 276 In Stock
10MG 394 In Stock
25MG 616 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (Rac)-Naxifylline
  • Note
    Research use only, not for human use.
  • Brief Description
    (Rac)-Naxifylline may be used to study congestive heart failure.
  • Description
    (Rac)-Naxifylline may be used to study congestive heart failure.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    166181-76-6
  • Formula Weight
    344.41
  • Molecular Formula
    C18H24N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C=2NC(=NC2N(C(=O)N1CCC)CCC)C3CC4CC3C5OC54
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 4-Methoxycoumarine

    4-Methoxycoumarine has antitumour effects.Coumarin has antitumour effects in vivo and cytostatic effects in vitro. Its half-life in humans is short (1-1.5 h) and the monohydroxylated biotransformation products have significantly longer half-lives.

  • [Des-Ala1,des-Gly2,H...

    [Des-Ala1,des-Gly2,His4,5,D-Trp8]-Somatostatin-14

  • [Pro3]-GIP (Mouse)

    GIP receptor antagonist (IC50 = 2.6μM). Inhibits GIP-stimulated insulin release from pancreatic β cells in vitro. In ob/ob mice, blocks the effects of GIP on insulin release and plasma glucose levels. Also improves intraperitoneal glucose tolerance, insulin sensitivity, and glucose response to feeding in ob/ob mice.